{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:05:03Z","timestamp":1786118703202,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1097\/ftd.0b013e3180311384","type":"journal-article","created":{"date-parts":[[2007,2,15]],"date-time":"2007-02-15T03:58:32Z","timestamp":1171511912000},"page":"20-26","source":"Crossref","is-referenced-by-count":32,"title":["A Limited Sampling Strategy for Estimating Individual Pharmacokinetic Parameters of Coagulation Factor VIII in Patients With Hemophilia A"],"prefix":"10.1097","volume":"29","author":[{"given":"Magali","family":"Bolon-Larger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Chamouard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Bressolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roselyne","family":"Boulieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210129","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2165\/00003088-200140110-00003","article-title":"Pharmacokinetics of coagulation factors.","volume":"40","author":"Bjorkman","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"R2-4-20210129","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/BF01240143","article-title":"Limited-sampling models for anticancer agents.","volume":"120","author":"Van Warmerdam","year":"1994","journal-title":"J Cancer Res Clin Oncol"},{"key":"R3-4-20210129","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/j.1552-4604.1998.tb04431.x","article-title":"Development of a limited sampling approach in pharmacokinetic studies: experience with the antiepilepsy drug tiagabine.","volume":"38","author":"Mahmood","year":"1998","journal-title":"J Clin Pharmacol"},{"key":"R4-4-20210129","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1128\/AAC.47.10.3170-3178.2003","article-title":"Population pharmacokinetics of ciprofloxacine in pediatric and adolescent patients with acute infections.","volume":"47","author":"Payen","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"R5-4-20210129","first-page":"95","article-title":"Individualization of factor VIII dosage.","volume":"9","author":"Messori","year":"1984","journal-title":"J Clin Hosp Pharm"},{"key":"R6-4-20210129","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/BF00637604","article-title":"Multi-variate analysis of factors governing the pharmacokinetics of exogenous factor VIII in haemophiliacs.","volume":"35","author":"Messori","year":"1988","journal-title":"Eur J Clin Pharmacol"},{"key":"R7-4-20210129","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0010-468X(85)90008-X","article-title":"A calculator program for clinical application of the Bayesian method of predicting plasma drug levels.","volume":"19","author":"Ruffo","year":"1985","journal-title":"Comput Programs Biomed"},{"key":"R8-4-20210129","first-page":"225","article-title":"Estimation of human body surface area from height and weight.","volume":"54","author":"Gehan","year":"1970","journal-title":"Cancer Chemother Rep"},{"key":"R11-4-20210129","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF02294361","article-title":"Model selection and Akaikes information criteria (AIC): the general theory and its analytical extension.","volume":"52","author":"Bozdogan","year":"1987","journal-title":"Psychometrika"},{"key":"R12-4-20210129","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF01062273","article-title":"Experimental design and efficient parameter estimation in population pharmacokinetics.","volume":"18","author":"al-Banna MK, Kelman","year":"1990","journal-title":"J Pharmacokinet Biopharm"},{"key":"R13-4-20210129","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/j.1552-4604.1991.tb03657.x","article-title":"Optimal sampling theory and population modelling: application to determination of the influence of the microgravity environment on drug distribution and elimination.","volume":"31","author":"Drusano","year":"1991","journal-title":"J Clin Pharmacol"},{"key":"R15-4-20210129","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1128\/AAC.34.6.1165","article-title":"Application of a Bayesian method to monitor and adjust vancomycin dosage regimens.","volume":"34","author":"Hurst","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"R16-4-20210129","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF01060893","article-title":"Some suggestions for measuring predictive performance.","volume":"9","author":"Sheiner","year":"1981","journal-title":"J Pharmacokinet Biopharm"},{"key":"R17-4-20210129","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/BF01061030","article-title":"Evaluation of methods for estimating population pharmacokinetic parameters II Biexponential model and experimental pharmacokinetic data.","volume":"9","author":"Sheiner","year":"1981","journal-title":"J Pharmacokinet Biopharm"},{"key":"R18-4-20210129","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0169-2607(86)90078-7","article-title":"A microcomputer program for individualizing factor VIII dosage in haemophilia patients undergoing major surgery.","volume":"23","author":"Ruffo","year":"1986","journal-title":"Comput Methods Programs Biomed"},{"key":"R19-4-20210129","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1600-0609.1985.tb00739.x","article-title":"Kinetic evaluation of four factor VIII concentrates by model-independent methods.","volume":"34","author":"Matucci","year":"1985","journal-title":"Scand J Haematol"},{"key":"R20-4-20210129","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0049-3848(86)90210-0","article-title":"Pharmacokinetics of a new heat-treated concentrate of factor VIII estimated by model-independent methods.","volume":"42","author":"Longo","year":"1986","journal-title":"Thromb Res"},{"key":"R21-4-20210129","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0049-3848(91)90105-6","article-title":"Comparative evaluation of the pharmacokinetics of three monoclonal factor VIII concentrates.","volume":"61","author":"Morfini","year":"1991","journal-title":"Thromb Res"},{"key":"R22-4-20210129","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1055\/s-0038-1646292","article-title":"Pharmacokinetic properties of recombinant factor VIII compared with a monoclonally purified concentrate (Hemofil M).","volume":"68","author":"Morfini","year":"1992","journal-title":"Thromb Haemost"},{"key":"R23-4-20210129","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/0049-3848(92)90109-N","article-title":"Pharmacokinetics of two pasteurized factor VIII concentrates by different and multicenter assays of factor VIII activity.","volume":"65","author":"Messori","year":"1992","journal-title":"Thromb Res"},{"key":"R25-4-20210129","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1055\/s-0038-1650691","article-title":"Pharmacokinetic in vivo comparison using 1-stage and chromogenic substrate assays with two formulations of haemophil-M.","volume":"76","author":"Lee","year":"1996","journal-title":"Thromb Haemost"},{"key":"R26-4-20210129","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/s-0038-1655957","article-title":"Recombinant, B-domain deleted factor VIII: pharmacokinetics and initial safety aspects in haemophilia A patients.","volume":"77","author":"Fijnvandraat","year":"1997","journal-title":"Thromb Haemost"},{"key":"R27-4-20210129","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1046\/j.1351-8216.2002.00136.x","article-title":"Comparative pharmacokinetic studies in haemophilia.","volume":"8","author":"Morfini","year":"2002","journal-title":"Haemophilia"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0b013e3180311384","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:30:12Z","timestamp":1786033812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007691-200702000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e3180311384","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}